GlassScriptPhysician profile
Catherine De Luca
NPI 1548265580
$6,479.80
in general payments reported to CMS, 2019-2025
45 companies · $1,193 in 2025
The $1,193 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,279 · 2020: $240 · 2021: $737 · 2022: $1,107 · 2023: $618 · 2024: $1,306 · 2025: $1,193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,116.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,051.69 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $672.99 | 2019-2025 | |
| Amgen INC. | $605.74 | 2019-2025 | Repatha, Otezla, Evenity |
| Abbvie INC. | $468.27 | 2019-2025 | Ubrelvy, Qulipta |
| Lilly USA, LLC | $435.04 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $367.65 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $302.17 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Exact Sciences Corporation | $223.38 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $197.89 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $181.51 | 2021 | |
| Avanir Pharmaceuticals, INC. | $177.47 | 2019-2022 | |
| Boston Scientific Corporation | $127.40 | 2024 | |
| Glaxosmithkline, LLC. | $108.23 | 2019-2023 | Arexvy, Shingrix |
| Novartis Pharmaceuticals Corporation | $107.84 | 2019-2025 | |
| Medtronic, INC. | $106.99 | 2022-2024 | Intellis Adaptivestim |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine De Luca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.